| 000 | 01751 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516050533.0 | ||
| 264 | 0 | _c20120325 | |
| 008 | 201203s 0 0 eng d | ||
| 022 | _a1573-7373 | ||
| 024 | 7 |
_a10.1007/s11060-011-0648-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGessi, Marco | |
| 245 | 0 | 0 |
_ap53 expression predicts dismal outcome for medulloblastoma patients with metastatic disease. _h[electronic resource] |
| 260 |
_bJournal of neuro-oncology _cJan 2012 |
||
| 300 |
_a135-41 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aBiomarkers, Tumor |
| 650 | 0 | 4 |
_aCerebellar Neoplasms _xdiagnosis |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 |
_aDNA, Neoplasm _xbiosynthesis |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xgenetics |
| 650 | 0 | 4 |
_aGenes, myc _xgenetics |
| 650 | 0 | 4 |
_aGenes, p53 _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMedulloblastoma _xdiagnosis |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aNeoplasm Metastasis _xgenetics |
| 650 | 0 | 4 | _aPoint Mutation |
| 650 | 0 | 4 | _aPolymorphism, Single-Stranded Conformational |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aYoung Adult |
| 650 | 0 | 4 |
_abeta Catenin _xgenetics |
| 700 | 1 | _avon Bueren, André O | |
| 700 | 1 | _aRutkowski, Stefan | |
| 700 | 1 | _aPietsch, Torsten | |
| 773 | 0 |
_tJournal of neuro-oncology _gvol. 106 _gno. 1 _gp. 135-41 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s11060-011-0648-8 _zAvailable from publisher's website |
| 999 |
_c21042415 _d21042415 |
||